AcuCort AB (publ) (XSAT:ACUC)
Sweden · Delayed Price · Currency is SEK 0.6220
-0.0060 (-0.96%)
At close: Aug 6, 2026
AcuCort AB Revenue
AcuCort AB had revenue of 2.15M SEK in the quarter ending March 31, 2026, with 54.01% growth. This brings the company's revenue in the last twelve months to 7.44M, down -6.18% year-over-year. In the year 2025, AcuCort AB had annual revenue of 6.68M, down -13.40%.
Revenue (ttm)
7.44M
Revenue Growth
-6.18%
P/S Ratio
19.61
Revenue / Employee
n/a
Employees
5
Market Cap
145.82M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 6.68M | -1.03M | -13.40% |
| Dec 31, 2024 | 7.72M | 1.13M | 17.07% |
| Dec 31, 2023 | 6.59M | 1.57M | 31.24% |
| Dec 31, 2022 | 5.02M | 1.56M | 45.05% |
| Dec 31, 2021 | 3.46M | 1.94M | 126.68% |
| Dec 31, 2020 | 1.53M | -2.53M | -62.35% |
| Dec 31, 2019 | 4.06M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Bergholm Holding AB | 593.52M |
| Gullberg & Jansson AB | 261.44M |
| SolidX AB | 137.67M |
| BPC Instruments AB | 65.79M |
| QBNK Holding AB | 40.26M |
| PEPTONIC medical AB | 14.17M |
| Dextech Medical AB | 4.15M |
| Smoltek Nanotech Holding AB | 4.10M |
AcuCort AB News
- 3 months ago - AcuCort AB Quarterly report: Q1 2026 - Filings
- 5 months ago - AcuCort AB Slides: FY 2026 - Filings
- 6 months ago - AcuCort AB Annual report: Q4 2025 - Filings
- 6 months ago - AcuCort AB Quarterly report: Q4 2025 - Filings
- 9 months ago - AcuCort AB Quarterly report: Q3 2025 - Filings
- 1 year ago - AcuCort AB Quarterly report: Q2 2025 - Filings